ASTRAZEN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astrazeneca Pharma India Ltd

Watchlist Manager

Watchlist

Price: 6 669 INR -0.51% Market Closed

Market Cap: ₹166.7B

	Astrazeneca Pharma India Ltd NSE:ASTRAZEN	IN
	Thob Al Aseel Company SJSC SAU:4012	SA
	Fukui Computer Holdings Inc OTC:FKCIF	JP
F	Fluence Corporation Ltd F:4SVE	US
	Ferro-Alloy Resources Ltd LSE:FAR	GG
S	Shinwon Construction Co Ltd KOSDAQ:017000	KR
	North Energy ASA F:RN2	NO

Profitability Summary

Astrazeneca Pharma India Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Sustainable 3Y Average Gross Margin

46%

Declining Gross Margin

64% > 37%

Low Operating Margin

Sustainable 3Y Average Operating Margin

12%

Declining Operating Margin

18% > 9%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

12% > 7%

Negative Free Cash Flow Margin

-1%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

5% > -1%

Positive ROE

21%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

38%

Declining ROIC

62% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.